Liver neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.
|
19233941 |
2009 |
Precancerous Conditions
|
0.300 |
Biomarker
|
group |
CTD_human |
Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.
|
19233941 |
2009 |
Condition, Preneoplastic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.
|
19233941 |
2009 |
Malignant neoplasm of liver
|
0.300 |
Biomarker
|
disease |
CTD_human |
Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.
|
19233941 |
2009 |
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
|
29326435 |
2019 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Breast Carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
|
21123754 |
2011 |
Autoimmune Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The study provides insights into the role of CCDC134 as a unique therapeutic agent for the treatment of autoimmune diseases.
|
29548993 |
2018 |
Encephalomyelitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we found that CCDC134 expression was markedly increased in the spinal cord during the progression of EAE.
|
29548993 |
2018 |
Multiple Sclerosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
However, the dynamic changes in CCDC134 expression patterns in the spinal cord that may be involved in the progression of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, remains unclear.
|
29548993 |
2018 |
Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Amelioration of adjuvant-induced arthritis in CCDC134-overexpressing transgenic mice.
|
28571739 |
2017 |
Rheumatoid Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings indicate that overexpression of CCDC134 exerts potent anti-inflammatory effects through selective modulation of pathogenic Th1 and Th17 cells, and might provide insights into the role of CCDC134 as a unique therapeutic agent for the treatment of rheumatoid arthritis.
|
28571739 |
2017 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
However, the role of CCDC134 in cancer development is still lacking.
|
23070808 |
2013 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In vitro transient transfection of CCDC134-specific siRNA significantly promoted the migration and invasion of both the normal gastric epithelial cell line GES-1 and gastric cancer cell line AGS cells.
|
23070808 |
2013 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In vitro transient transfection of CCDC134-specific siRNA significantly promoted the migration and invasion of both the normal gastric epithelial cell line GES-1 and gastric cancer cell line AGS cells.
|
23070808 |
2013 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Besides, CCDC134-RNAi could induce the expression of MMP-2 and MMP-9, which are key molecules involved in regulating cell migration and invasion.
|
23070808 |
2013 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
However, the role of CCDC134 in cancer development is still lacking.
|
23070808 |
2013 |
Malignant transformation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Therefore, CCDC134 may be a candidate biomarker for malignant transformation.
|
23070808 |
2013 |